Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. “It also creates new opportunities for researchers, entrepreneurs, investors and pharmaceutical companies.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. A minimum of 5-7 years of legal experience in healthcare or pharmaceutical-related fields. Deputy General Counsel Executive Summary.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

OCTOBER 10, 2021

As a senior manager at Cantourage and with us as a team you can develop and shape the pharmaceuticals market in Europe. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). pharmacology, toxicology, chemistry).

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

JANUARY 12, 2022

“We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinical trials.” Following the required transfer of Gb Sciences’ cannabis production and extraction licenses to AJE Management, LLC by the Nevada Cannabis Compliance Board on Dec.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. After two years of a global pandemic, mental health conditions are a more urgent need than ever. About Psygen.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis. They can offer their drugs with an innovative inhaler device. The Strategic Imperative.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JANUARY 24, 2022

Accomplished leader to oversee Goldfinch Bio’s clinical function to advance precision medicines for people living with kidney disease. Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

JUNE 2, 2021

The Company is offering pooled surveillance testing in compliance with current CDC, FDA, and CMS guidances. Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Veriheal

OCTOBER 13, 2020

Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance. More research and clinical trials are needed to fully understand how cannabinoids help those suffering from GI pathologies. A Neuroscience Researcher Weighs in.

Digestion 123

Digestion Treatment Conditions Research and Development 123

Cannabis Law Report

SEPTEMBER 3, 2019

We are delighted to start working with this Licensed Producer, and others, who share our vision of providing the highest quality pharmaceutical-grade products. We are dedicated to making our compliance regimen second-to-none in Australia just as it is in Canada,” said Mr. McCutcheon.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

DECEMBER 7, 2021

It also affirms our long-standing confidence that Labat Africa, through the healthcare busines would find a smart and sustainable solution to meeting the global demand of the EU-GMP (good manufacturing practice) certification standard, which we are well positioned for as a supplier of Pharmaceutical Grade Medicinal Cannabis and Industrial Hemp.”.

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

Cannabis Law Report

JUNE 1, 2021

Prior to UroGen, Mr. Barbera held various leadership roles at Dendreon Pharmaceuticals, Allergan, and Medimmune, among others. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

NOVEMBER 12, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. On track to commence Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

SEPTEMBER 8, 2021

About Epsilon Healthcare Limited Epsilon Healthcare (ASX:EPN) is an ASX listed diversified global healthcare and pharmaceuticals company. EPN owns a number of medicinal cannabis assets including the largest GMP cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JULY 24, 2019

March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”. Office of Compliance. Office of Compliance. On your Twitter Social Media Account: • March 27, 2019 posting – “#ICBD to help lower anxiety.”. Sincerely, /s/. Eric Nelson.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

APRIL 8, 2019

Educational institutions, pharmaceutical companies and other scientific organisations can obtain, separately, a cannabis research licence. the person’s history of compliance with the NDA. In addition to a licence, a prospective medicinal cannabis producer will also require a medicinal cannabis permit. Licence preconditions.

Medicine 71

Medicine Research and Development Business Cannabis 71

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required).

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

MARCH 29, 2020

The guidelines below detail some prime facets to consider in order to maintain high quality control standards in the cannabis research space: o Compliance with the Cannabis Act and the MRIA Code of Conduct including referencing the guidelines listed in the Pharmaceutical Research section.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JUNE 3, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

NOVEMBER 12, 2021

THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. Business Cann Report.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

MARCH 1, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

SEPTEMBER 21, 2021

Do you think there should be a distinction between pharmaceutical cannabis companies vs cannabis grown for adult use retail? . Yes, pharmaceutical and adult-use retail cannabis are two completely different markets and user groups. What’s your view from Oregon.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

JANUARY 9, 2019

Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. For the communities, Phoenix can roll out much faster when part of a national healthcare system with clinics and infrastructure, said Tindall. “We We want to replicate that in the South Pacific, where they have 46 countries,” he said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

The Cannigma

FEBRUARY 11, 2021

So I had been on over 26 pharmaceuticals, including fentanyl, um, and, you name it. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. But we can also, back to what I said in my presentation today about compliance and what’s required for compliance. Elana: Right.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

OCTOBER 17, 2019

By passing the Cannabis Act, Canada has taken a position of principled non-compliance with its international drug treaty obligations,” says Fraser. Certain medical patients, such as those participating in clinical trials, can gain access to cannabis under the Therapeutic Goods Act 1989, with each state having its own regulations as well.

Law 40

Law Seed-To-Sale Hemp Recreational 40